Chronic and acute tolerance to subjective effects of nicotine. 1993

K A Perkins, and J E Grobe, and L H Epstein, and A Caggiula, and R L Stiller, and R G Jacob
Department of Psychiatry, University of Pittsburgh School of Medicine, PA 15213.

Tolerance to subjective effects of nicotine may induce novice smokers to increase the magnitude and frequency of their nicotine self-dosing. In this study, smokers (n = 8) and nonsmokers (n = 7) participated in three sessions involving presentation of 0, 7.5, or 15 micrograms/kg nicotine 30 min for 2 h via measured-dose nasal spray, with different doses presented on separate days. Subjective responses were assessed using visual analog scales (VASs) of jittery, light-headed, relaxed, dizzy, and head rush, and the Profile of Mood States (POMS) scales of vigor, confusion, fatigue, tension, and the composite scale of arousal. Smaller responses in smokers vs. nonsmokers were viewed as evidence for chronic tolerance. In addition, on each day subjects received a fifth, challenge dose of 30 micrograms/kg 30 min after the previous dosing. Smaller responses to the challenge dose as a function of increasing prior nicotine dosing during Trials 1-4 were viewed as evidence for acute tolerance. Results showed significant changes in most measures as a function of nicotine dose, and the dose-response curves for most VAS and POMS scales tended to be shifted to the right, or dampened, in smokers relative to nonsmokers, consistent with chronic tolerance. However, smokers and nonsmokers tended to respond to nicotine in opposite directions for POMS scales of vigor and arousal, perhaps reflecting withdrawal relief in smokers. Acute tolerance on a few selected VAS and POMS scales was apparent for both smokers and nonsmokers.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000339 Affect The feeling-tone accompaniment of an idea or mental representation. It is the most direct psychic derivative of instinct and the psychic representative of the various bodily changes by means of which instincts manifest themselves. Mood,Affects,Moods
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits

Related Publications

K A Perkins, and J E Grobe, and L H Epstein, and A Caggiula, and R L Stiller, and R G Jacob
January 1989, Psychopharmacology,
K A Perkins, and J E Grobe, and L H Epstein, and A Caggiula, and R L Stiller, and R G Jacob
December 1991, Drug and alcohol dependence,
K A Perkins, and J E Grobe, and L H Epstein, and A Caggiula, and R L Stiller, and R G Jacob
December 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco,
K A Perkins, and J E Grobe, and L H Epstein, and A Caggiula, and R L Stiller, and R G Jacob
February 1997, Pharmacology, biochemistry, and behavior,
K A Perkins, and J E Grobe, and L H Epstein, and A Caggiula, and R L Stiller, and R G Jacob
June 1973, Psychopharmacologia,
K A Perkins, and J E Grobe, and L H Epstein, and A Caggiula, and R L Stiller, and R G Jacob
December 1985, The Journal of pharmacology and experimental therapeutics,
K A Perkins, and J E Grobe, and L H Epstein, and A Caggiula, and R L Stiller, and R G Jacob
September 1994, Psychopharmacology,
K A Perkins, and J E Grobe, and L H Epstein, and A Caggiula, and R L Stiller, and R G Jacob
May 1994, Journal of neurochemistry,
K A Perkins, and J E Grobe, and L H Epstein, and A Caggiula, and R L Stiller, and R G Jacob
January 1989, Psychopharmacology,
K A Perkins, and J E Grobe, and L H Epstein, and A Caggiula, and R L Stiller, and R G Jacob
September 1993, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!